Due to fraudulence and misconduct in research, advances in Alzheimer’s Disease treatments have been hindered. Read More.
Other Posts
Technology, Policy, and Governance
A recent update from the Technoprogressive Initiative, led by bioethicist James J. Hughes and his colleagues, look at how technology and policy continue to intersect. It centers on the role of governance in guiding innovation [...]
U.S. Global Aid and Maternal Health Outcomes
Recent research shows a link between shifts in U.S. global aid funding and maternal mortality in aid-dependent countries. These patterns have varied across both Republican and Democratic administrations. Access to reproductive health services remains critical [...]
Euthanasia and Decision-Making: A Case from Spain
A recent case in Spain followed a 25-year-old woman whose request for euthanasia led to a prolonged legal process. Courts ultimately upheld her right under Spain’s euthanasia law after challenges from family members and extended [...]
A Closer Look at Dr. Frederick L. Licciardi
We are pleased to spotlight a valued board member of our Bioethics Education organization, Dr. Frederick L. Licciardi, MD, a Professor in the Department of Obstetrics and Gynecology at NYU Grossman School of Medicine and [...]
Biodeterrence in the Age of Dual-Use Technology
A 2026 National Defense University report from Dr. Giordano lays out how biodeterrence must extend beyond biological weapons to any action that produces biological harm, blurring traditional boundaries. This shift calls for coordinated responses across [...]
Between Choice and Protection in Mental Health
A recent article from The Atlantic talks about a Dutch psychiatrist who administered euthanasia to psychiatric patients including teenagers. These cases raise a difficult tension between autonomy versus vulnerability and choice versus illness. In the Netherlands, [...]
